The compound TB47 is highly bactericidal against Mycobacterium ulcerans in a Buruli ulcer mouse model
Combination therapy for Buruli ulcer (BU) is suboptimal. Here, Liu et al. show that the candidate drug TB47 has potent bactericidal activity against Mycobacterium ulcerans in vitro and in a mouse model, which underscores its potential for shortening the course of BU and treating other mycobacterial...
Main Authors: | , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2019-01-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/s41467-019-08464-y |